Alphatec Spine, Inc. Announces the First Three-Level Guided Lumbar Interbody Fusion Procedure Performed Using the Revolutionary
04 Januar 2011 - 3:15PM
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of
Alphatec Spine, Inc., a medical device company that designs,
develops, manufactures and markets products for the surgical
treatment of spine disorders, with a focus on treating conditions
related to the aging spine, today announced the first ever
three-level Guided Lumbar Interbody Fusion (GLIF) procedure
performed by Morgan Lorio, MD FACS of Bristol, TN. GLIF is the only
lateral approach on the market today that provides the surgeon the
ability to perform a 360-degree correction without repositioning
the patient. The revolutionary GLIF technique and ARC Portal
Access System is designed to allow surgeons to perform lateral
interbody fusion procedures with the opportunity for less
intra-operative blood loss and minimized tissue disruption; while
decreasing the recovery time for most patients.
Dr. Morgan Lorio, an orthopedic spine surgeon at Neurospine
Solutions in Bristol, TN completed the first three-level procedure
using the proprietary ARC Portal Access System and instrumentation
designed specifically for the GLIF technique. This system
provides lateral access with direct visualization to the
intervertebral disc space while allowing the patient to remain in
the prone position. When augmented with posterior pedicle
fixation, the ARC system eliminates the need to reposition the
patient intra-operatively, thereby reducing the overall length of
the lateral lumbar fusion procedure and potentially reducing
operating room costs. "The GLIF system allowed me to achieve
correction in a minimally invasive and timely manner that would not
otherwise be possible with any other procedure currently on the
market. The differentiated and unique dorso-lateral approach
allows you to access both anterior and posterior elements of the
spine to allow for a true 360-degree correction," stated Dr.
Lorio. The operation was performed on a 62-year old male
patient with spinal instability and developmental stenosis
associated with adjacent level degeneration.
Dirk Kuyper, President and CEO of Alphatec Spine said, "We
believe the GLIF technique significantly advances the direct
lateral approach in the form of a less-invasive and more-efficient
lateral interbody fusion technique and the ability to perform a
360-degree procedure without repositioning the patient."
In 2010, the U.S. market for minimally invasive interbody fusion
devices is estimated to exceed $600 million (iData2010).
About Alphatec Spine
Alphatec Spine, Inc. is a wholly owned subsidiary of Alphatec
Holdings, Inc. (Nasdaq:ATEC). Alphatec Spine is a medical device
company that designs, develops, manufactures and markets products
for the surgical treatment of spine disorders, primarily focused on
the aging spine. The Company's mission is to combine
world-class customer service with innovative, surgeon-driven design
that will help improve the aging patient's quality of
life. The Company is poised to achieve its goal through new
solutions for patients with osteoporosis, stenosis and other aging
spine deformities, improved minimally invasive products and
techniques and integrated biologics solutions. In addition to
its U.S. operations, the Company also markets its products in over
50 international markets through its subsidiary, Scient'x S.A., via
a direct sales force in France, Italy and the United Kingdom and
via independent distributors in the rest of Europe, the Middle East
and Africa, South America and Latin America. In Asia and
Australia, the Company markets its products through its subsidiary,
Alphatec Pacific, Inc, and through Scient'x's distributors in
China, Korea and Australia.
Also visit the Aging Spine Center, www.agingspinecenter.com, a
web-based information portal for healthcare providers and patients
regarding aging spine disorders and their treatment. Alphatec
Spine is working with the National Osteoporosis Foundation as well
as other clinical portals that provide peer-reviewed content, to
populate the Aging Spine Center. The interactive website will
enable patients to review pertinent information about all the key
disorders that affect the aging spine in an easy-to-understand
format that includes videos, graphics and questions that should be
asked of caregivers. Medical information will include published
abstracts regarding the aging spine.
The Alphatec Holdings, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=3520
Forward Looking Statements
This press release may contain "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act
of 1995 that involve risks and uncertainty. Such statements are
based on management's current expectations and are subject to a
number of risks and uncertainties that could cause actual results
to differ materially from those described in the forward-looking
statements. These forward-looking statements include, but are not
limited to: Alphatec Spine's ability to accelerate new product
momentum, bring to market differentiated products and commercialize
its product pipeline. Alphatec Spine cautions investors that there
can be no assurance that actual results or business conditions will
not differ materially from those projected or suggested in such
forward-looking statements as a result of various factors,
including, but not limited to, the following: Alphatec Spine's
ability to meet its financial guidance, the growth rate of the
spine market related to aging and elderly patients, uncertainty of
success in developing new products or products currently in
Alphatec Spine's pipeline, including GLIF or the ARC system, and
those products that are intended to treat disorders prevalent in
aging patients, failure to achieve acceptance of Alphatec Spine's
products, including GLIF or the ARC system, by the surgeon
community, failure to obtain FDA clearance or approval for new
products, or unexpected or prolonged delays in the process,
including without limitation GLIF or the ARC system, Alphatec
Spine's ability to develop and expand its business in the United
States, Asia and Europe, continuation of favorable third party
payor reimbursement for procedures performed using Alphatec Spine's
products, unanticipated expenses or liabilities or other adverse
events affecting cash flow or Alphatec Spine's ability to
successfully control its costs or achieve profitability,
uncertainty of additional funding, Alphatec Spine's ability to
compete with other competing products and with emerging new
technologies, product liability exposure, patent infringement
claims and claims related to Alphatec Spine's intellectual
property. Please refer to the risks detailed from time to time in
Alphatec Spine's SEC reports, including quarterly reports on Form
10-Q, reports on Form 8-K and annual reports on Form 10-K. Alphatec
Spine disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events, or otherwise, unless required by law.
CONTACT: Alphatec Spine, Inc.
Michael O'Neill, Chief Financial Officer
(760) 494-6746
investorrelations@alphatecspine.com
Westwicke Partners
Lynn C. Pieper
(415) 202-5678
lynn.pieper@westwicke.com
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
Von Jul 2023 bis Jul 2024